Related scientific articles (all)

Menopausal hormone therapy use in 17 European countries during the last decade.

Authors : Ameye L, Antoine C, Paesmans M, de Azambuja E, Rozenberg S
Year : 2014
Journal : Maturitas
Volume : 79(3)
Pages : 287-91

Guidelines of clinical practice made by the European Lung Cancer Working Party: updates.

Authors : Berghmans T, Cortot A, CsToth I, Garcia C, Giner-Marco V, Grigoriu B, Holbrechts S, Lafitte JJ, Meert AP, Moretti L, Paesmans M, Remmelink M, Richez M, Roelandts M, Scherpereel A, Tulippe C, Van Houtte P, Sculier JP
Year : 2014
Journal : Rev Med Brux
Volume : 35(3)
Pages : 132-3

Single high intensity focused ultrasound session as a whole gland primary treatment for clinically localized prostate cancer: 10-year outcomes.

Authors : Limani K, Aoun F, Holz S, Paesmans M, Peltier A, Van Velthoven R
Year : 2014
Journal : Prostate Cancer
Volume : 2014(null)
Pages : 186782

Parathyroidectomy in primary hyperparathyroidism: retrospective study of 167 patients, experience in Jules Bordet Institute.

Authors : Quiriny M, Moreau M, Alexiou J, Andry G
Year : 2014
Journal : Acta Chir Belg
Volume : 114(2)
Pages : 118-24

Treatment of climacteric symptoms in breast cancer patients : A retrospective study from a medication databank.

Authors : Antoine C, Ameye L, Paesmans M, Rozenberg S
Year : 2014
Journal : Maturitas
Volume : 78
Pages : 228-232

Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient's outcome in advanced colorectal cancer: the CORIOLAN study.

Authors : Deleporte A, Paesmans M, Garcia C, Vandeputte C, Lemort M, Engelholm JL, Hoerner F, Aftimos P, Awada A, Charette N, Machiels G, Piccart-Gebhart M, Flamen P, Hendlisz A
Year : 2014
Journal : BMC Cancer
Volume : 14(1)
Pages : 385

Prognostic, predictive abilities and concordance of BCL2 and TP53 protein expression in primary breast cancers and axillary lymph-nodes: A retrospective analysis of the Belgian three arm study evaluating anthracycline vs CMF adjuvant chemotherapy.

Authors : Bozovic-Spasojevic I, Ameye L, Paesmans M, Larsimont D, Di Leo A, Dolci S, Piccart-Gebhart M, de Azambuja E, Loi S
Year : 2014
Journal : Breast
Volume : 23(4)
Pages : 473-81

The European initiative for quality management in lung cancer care.

Authors : Blum TG, Rich A, Baldwin D, Beckett P, De Ruysscher D, Faivre-Finn C, Gaga M, Gamarra F, Grigoriu B, Hansen NC, Hubbard R, Huber RM, Jakobsen E, Jovanovic D, Konsoulova A, Kollmeier J, Massard G, McPhelim J, Meert AP, Milroy R, Paesmans M, Peake M, Putora PM, Scherpereel A, Schönfeld N, Sitter H, Skaug K, Spiro S, Strand TE, Taright S, Thomas M, Van Schil PE, Vansteenkiste JF, Wiewrodt R, Sculier JP
Year : 2014
Journal : Eur. Respir. J.
Volume : 43(5)
Pages : 1254-1277

Controversial Issues in Early Stage Breast Cancer: a Global Collaborative Survey, supported by the European Society for Medical Oncology (ESMO).

Authors : Zardavas D, Ades F, Spasojevic IB, Pugliano L, Capelan M, Paesmans M, de Azambuja E, Piccart-Gebhart M
Year : 2014
Journal : Ann Oncol
Volume : 25(8)
Pages : 1558-62

The landscape of medical oncology in Europe by 2020.

Authors : de Azambuja E, Ameye L, Paesmans M, Zielinski CC, Piccart-Gebhart M, Preusser M
Year : 2014
Journal : Ann Oncol
Volume : 25(2)
Pages : 525-8

Systematic review about breast cancer incidence in relation to hormone replacement therapy use.

Authors : Antoine C, Ameye L, Paesmans M, Rozenberg S
Year : 2014
Journal : Climacteric
Volume : 17(2)
Pages : 116-32

Single-access laparoscopic primary and incisional prosthetic hernia repair: first 50 patients.

Authors : Dapri G, Bruyns J, Paesmans M, Himpens J, Cadière GB
Year : 2013
Journal : Hernia
Volume : 17(5)
Pages : 619-26

The lung cancer patient at the emergency department: A three-year retrospective study.

Authors : Gorham J, Ameye L, Berghmans T, Sculier JP, Meert AP
Year : 2013
Journal : Lung Cancer
Volume : 80(2)
Pages : 203-8.

Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy--EORTC Infe

Authors : Kern WV, Marchetti O, Drgona L, Akan H, Aoun M, Akova M, De Bock R, Paesmans M, Viscoli C, Calandra T
Year : 2013
Journal : J. Clin. Oncol.
Volume : 31(9)
Pages : 1149-56

Non-malignant causes of hypercalcemia in cancer patients: a frequent and neglected occurrence.

Authors : Soyfoo MS, Brenner K, Paesmans M, Body JJ
Year : 2013
Journal : Support Care Cancer
Volume : 21(5)
Pages : 1415-19

Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.

Authors : Azim HA, Kroman N, Paesmans M, Gelber S, Rotmensz N, Ameye L, De Mattos-Arruda L, Pistilli B, Pinto A, Jensen MB, Cordoba O, de Azambuja E, Goldhirsch A, Piccart-Gebhart M, Peccatori FA
Year : 2013
Journal : J. Clin. Oncol.
Volume : 31(1)
Pages : 73-9

Comparison of a gene expression profiling strategy to standard clinical work-up for determination of tumour origin in cancer of unknown primary (CUP).

Authors : Ades F, de Azambuja E, Daugaard G, Ameye L, Moulin C, Paesmans M, De Jong D, Decoster L, De Greve J, Ismael G, Møller AK, Piccart-Gebhart M, Awada A
Year : 2013
Journal : J Chemother
Volume : 25(4)
Pages : 239-46

An ELCWP phase III trial comparing ifosfamide and cisplatin regimens in advanced NSCLC.

Authors : Berghmans T, Lafitte JJ, Scherpereel A, Paesmans M, Lecomte J, Marco VG, Meert AP, Leclercq N, Sculier JP
Year : 2013
Journal : Anticancer Res
Volume : 33(12)
Pages : 5477-82

Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study.

Authors : Berghmans T, Ameye L, Willems L, Paesmans M, Mascaux C, Lafitte JJ, Meert AP, Scherpereel A, Cortot AB, CsToth I, Dernies T, Toussaint L, Leclercq N, Sculier JP
Year : 2013
Journal : Lung Cancer
Volume : 82(2)
Pages : 340-5

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial.

Authors : de Azambuja E, Zardavas D, Lemort M, Rossari J, Moulin C, Buttice A, Dhondt V, Lebrun F, Lalami Y, Cardoso F, Sotiriou C, Gil T, Devriendt D, Paesmans M, Piccart-Gebhart M, Awada A
Year : 2013
Journal : Ann Oncol
Volume : 24(12)
Pages : 2985-9